Biosimilars available from Cencora
We believe in the promise of biosimilars to deliver cost savings across healthcare and we have access to every approved biosimilars launched in the United States. We also understand the potential hurdles these unique products will face. That's why we offer solutions for increasing access to and confidence in these emerging therapies.
To date, there have been 69 approvals and 49 launches* in the U.S. biosimilar market. Biosimilars are a promising product category, one that can provide patients and doctors with more affordable treatment options. With increased biosimilar adoption, we can improve medication access and affordability, and better support the patients we serve.
Below you will find the biosimilars available through Cencora in the US.
| Biosimilar | Reference product | Patient support services | Drug information |
|---|---|---|---|
| Tyenne (tocilizumab-aazg) |
Actemra® |
https://www.tyennehcp.com/get-to-know-tyenne |
Read more |
| Tofidence (tocilizumab-bavi) |
Actemra® |
https://www.tofidencehcp.com/ |
Read more |
| Mvasi (bevacizumab-awwb) | Avastin® | Amgen Assist 360TM | Read more |
| Zirabev (bevacizumab-bvzr) | Avastin® | Pfizer Oncology TogetherTM | Read more |
| Alymsys (bevacizumab-maly) | Avastin® | Amneal PATHways® | Read more |
| Vegzelma (bevacizumab-adcd) | Avastin® | Vegzelma patient support | Read more |
| Retacrit (epoetin alfa-epbx) | Epogen/Procrit® | Pfizer enCompass® | Read more |
| Pavblu (aflibercept-ayyh) |
Eylea |
https://www.pavblu.com/ |
Read more |
| Kanjinti (trastuzumab-anns) | Herceptin® | Amgen Assist 360TM | Read more |
| Ogiviri (trastuzumab-dkst) | Herceptin® | Viatris Advocate® | Read more |
| Ontruzant (trastuzumab-dttb) | Herceptin® | Organon Access Program | Read more |
| Trazimera (trastuzumab-qyyp) | Herceptin® | Pfizer Oncology TogetherTM | Read more |
| Herzuma (trastuzumab-pkrb) | Herceptin® | Teva Shared Solutions® | Read more |
| Hercessi (trastuzumab-strf) | Herceptin® | https://www.hercessihcp.com/patient-support/ |
Read more |
| Amjevita (adalimumab-atto) | Humira® | AMJEVITA SupportPlus Co-Pay program | Read more |
| Cyltezo (adalimumab-adbm) | Humira® | BI Cares Patient Assistance Program | Read more |
| Hadlima (adalimumab-bwwd) | Humira® | Hadlima patient support | Read more |
| Hulio (adalimumab-fkjp) | Humira® | Hulio360 | Read more |
| Hyrimoz (adalimumab-adaz) | Humira® | Sandoz One Source | Read more |
| Idacio (adalimumab-aacf) | Humira® | Kabicare | Read more |
| Yuflyma (adalimumab-aaty) | Humira® | Celltrion Connect | Read more |
| Yusimry (adalimumab-aqvh) | Humira® | Patient Support Services | Read more |
| Abrilada (adalimumab-afzb) | Humira® | Pfizer enCompass® | Read more |
| Simlandi (adalimumab-ryvk) |
Humira® | https://www.simlandi.com/ | Read more |
| Rezvoglar (insulin glargine-aglr) | Lantus® | Rezvoglar support information | Read more |
| Semglee (insulin glargine-yfgn) | Lantus® | Semglee Savings and Support | Read more |
| Byooviz (ranibizumab-nuna) | Lucentis® | Biogen Biosimilar Support Services | Read more |
| Cimerli (ranibizumab-eqrn) | Lucentis® | Cimerli SolutionsTM | Read more |
| Fulphila (pegfilgrastim-jmdb) | Neulasta® | Viatris Advocate® | Read more |
| Fylnetra (pegfilgrastim-pbbk) | Neulasta® | Amneal PATHways® Patient Support Program | Read more |
| Udenyca (pegfilgrastim-cbqv) | Neulasta® | Coherus SolutionsTM | Read more |
| Ziextenzo (pegfilgrastim-bmez | Neulasta® | Sandoz One Source | Read more |
| Nyvepria (pegfilgrastim-apgf) | Neulasta® | Pfizer Oncology TogetherTM | Read more |
| Stimufend (pegfilgrastim-fpgk) | Neulasta® | KabiCare | Read more |
| Nivestym (filgrastim-aafi) | Neupogen® | Pfizer Oncology TogetherTM | Read more |
| Releuko (filgrastim-ayow) | Neupogen® | Amneal PATHways® | Read more |
| Zarxio (filgrastim-sndz) | Neupogen® | Sandoz One Source | Read more |
| Avsola (infliximab-axxq) | Remicade® | Amgen Assist® | Read more |
| Inflectra (infliximab-dyyb) | Remicade® | Pfizer enCompass® | Read more |
| Renflexis(infliximab-abda) | Remicade® | Organon Access Program | Read more |
| Riabni (rituximab-arrx) | Rituxan® | Amgen Assist 360® | Read more |
| Ruxience (rituximab-pvvr) | Rituxan® | Pfizer Oncology TogetherTM | Read more |
| Truxima (rituximab-abbs) | Rituxan® | Teva Shared Solutions® | Read more |
| Wezlana (ustekinumab-auub) |
Stelara |
https://www.wezlana.com/ |
Read more |
| Selarsdi (ustekinumab-aekn) |
Stelara |
https://www.selarsdi.com/savings-and-support/ |
Read more |
| Pyzchiva (ustekinumab-ttwe) |
Stelara |
https://sandoz-onesource.com/pyzchiva/ |
Read more |
| Otulfi (ustekinumab-aauz) |
Stelara |
https://www.kabicare.us/ |
Read more |
| Steqeyma (ustekinumab-stba) |
Stelara | https://steqeyma.com/support/ |
Read more |
| Yesintek (ustekinumab-kfce) |
Stelara |
https://yesintek.com/savings-and-support/ |
Read more |
Related resources
Cencora.com fournit des traductions automatiques pour faciliter la lecture du site Web dans des langues autres que l’anglais. Pour ces traductions, des efforts raisonnables ont été faits pour fournir une traduction précise, cependant, aucune traduction automatique n’est parfaite et n’est pas destinée à remplacer les traducteurs humains. Ces traductions sont fournies en tant que service aux utilisateurs de Cencora.com et sont fournies « en l’état ». Aucune garantie d’aucune sorte, expresse ou implicite, n’est donnée quant à l’exactitude, la fiabilité ou l’exactitude de ces traductions effectuées de l’anglais vers une autre langue. Certains contenus (tels que les images, les vidéos, Flash, etc.) peuvent ne pas être traduits avec précision en raison des limitations du logiciel de traduction.
Toute divergence ou différence créée lors de la traduction de ce contenu de l’anglais vers une autre langue n’est pas contraignante et n’a aucun effet juridique pour la conformité, l’application ou toute autre fin. Si des erreurs sont identifiées, veuillez nouscontacter. Si vous avez des questions sur l’exactitude des informations contenues dans ces traductions, veuillez vous référer à la version anglaise de la page.